Ceritinib is a tyrosine kinase inhibitor that selectively and potently inhibits anaplastic lymphoma kinase (ALK). In typical physiology, ALK features like a critical stage in the development and performance of nervous method tissue. However, chromosomal translocation and fusion give rise to an oncogenic form of ALK that has been implicated https://peterq887boy0.dailyblogzz.com/profile